In a previous study, oral IGF-I at 65 nM increased lactase phlorizin hydrolase (LPH) activity and villus height in piglets, however, the mechanisms were unknown. Herein, the response to a range of doses of IGF-I was investigated and we hypothesized that LPH and villus height would respond to oral IGF-I in a dose-dependent manner. Two 14-d experiments were conducted using cesarean-derived piglets. In experiment 1, piglets (n ϭ 28) were fed formula containing 0, 33, 65, or 131 nmol/L (0, 0.25, 0.5, or 1.0 mg/L) recombinant human IGF-I. In experiment 2, 5Ј-bromodeoxyuridine was administered to piglets fed formula alone (n ϭ 4) or containing 131 nmol/L IGF-I (n ϭ 4). IGF-I did not affect body weight gain or intestinal weight or length. Jejunal villus height and LPH activity were significantly greater in piglets fed 131 nmol IGF-I/L than control piglets. Abbreviations AP-1, activator protein-1 BrdU, 5Ј-bromodeoxyuridine C/EBP, CCAAT/enhancer binding protein EF1-␣, elongation factor 1-␣ FLE, foremost labeled enterocyte HNF-1, hepatocyte nuclear factor-1 LPH, lactase phlorizin hydrolase BB LPH, brush border lactase phlorizin hydrolase proLPH h , high mannose lactase phlorizin hydrolase precursor proLPH c , complex glycosylated lactase phlorizin hydrolase precursor MAPK, mitogen activated protein kinase NHS, normal horse serum PI 3-kinase, phosphatidylinositol 3-kinaseThe presence of IGF-I in colostrum and milk (1) and IGF receptors within the intestine (2) has led to the postulate that milk-borne IGF-I could play a role in neonatal intestinal development (3). Our group and others have shown that orally administered IGF-I stimulates intestinal villus growth (4 -6) and LPH activity (E.C. 3.2.1.23-62) (6) in the neonatal piglet.However, the doses of IGF-I administered in these experiments (65-1300 nmol/L) were above the concentrations of IGF-I present in porcine colostrum (13-52 nmol/L) or mature milk (1.3-2.6 nmol/L) (7). It was unknown whether oral administration of lower doses of IGF-I would exert similar biologic effects within the neonatal intestine. Further, the mechanisms by which oral IGF-I up-regulated intestinal LPH activity and villus growth had not been described. Therefore, the goals of the current study were to determine the impact of a range of doses of oral IGF-I on intestinal villus growth and LPH activity and to investigate potential mechanisms underlying these ef-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.